ELI LILLY & Co
Close on Nov 2, 2026Market cap $1.33TP/E 45.8Yield 0.44%
Eli Lilly Acquired in-process research and development charges by Year
Acquired in-process research and development (IPR&D) charges ($M) ($M)
Eli Lilly Acquired in-process research and development charges: $2,910M in FY2025, down 11.3% from a year earlier.
Where the FY2025 figure comes from
Source: Form 10-K (filed 2026-02-12) ↗
Reported in Form 10-Q / 10-K Consolidated Statements of Operations & Note 3.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Acquired in-process research and development (IPR&D) charges ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 2,910 | -11.3% | Form 10-K (filed 2026-02-12) ↗ |
| FY2024 | Dec 31, 2024 | 3,280 | -13.7% | Form 10-K (filed 2026-02-12) ↗ |
| FY2023 | Dec 31, 2023 | 3,800 | +318.3% | Form 10-K (filed 2026-02-12) ↗ |
| FY2022 | Dec 31, 2022 | 909 | -6.3% | Form 10-K (filed 2025-02-19) ↗ |
| FY2021 | Dec 31, 2021 | 970 | +46.9% | Form 10-K (filed 2024-02-21) ↗ |
| FY2020 | Dec 31, 2020 | 660 | +175.6% | Form 10-K (filed 2023-02-22) ↗ |
| FY2019 | Dec 31, 2019 | 240 | -87.9% | Form 10-K (filed 2022-02-23) ↗ |
| FY2018 | Dec 31, 2018 | 1,984 | +78.7% | Form 10-K (filed 2021-02-17) ↗ |
| FY2017 | Dec 31, 2017 | 1,110 | +3,600.0% | Form 10-K (filed 2020-02-19) ↗ |
| FY2016 | Dec 31, 2016 | 30 | – | Form 10-K (filed 2019-02-19) ↗ |
Breakdown
What makes up acquired in-process research and development charges
Cite this data
StockData. (2026). Eli Lilly Acquired in-process research and development charges ($M), annual FY2016–FY2025 [Data set]. Compiled from Eli Lilly SEC filings and investor materials. https://stockdatahq.com/stocks/lly/kpis/iprd-charges
See every metric in the Eli Lilly KPI table. Data updated Oct 25, 2026.